Australian (ASX) Stock Market Forum

Reply to thread

Re: BPO - BioProspect Limited




Been a while coming - but good and more importantly solid news should now flow.  After Eremophilone [Termilone base oil] gets its anticipated approvals,  product won't be far off the market, as R&D is running ahead of approval milestones [due to absolute confidence after trials and tests].  So it will be a matter of harvest and fraction Eremophilone for Termilone suite production. 


ReGen products into China I consider is a side show to Termilone but should be a quick and conststant cash spinner if it comes off.


Husbandry based Bioeffective product progress is an unknown ATM, but trial reports are positive so far. 


Today should be just the begining.


Top